1. Name and Address of Reporting Person* Mann Mic
Post# of 416
(Total Views: 362)
Posted On: 09/08/2017 1:35:47 PM
1. Name and Address of Reporting Person*
Mann Michael Scott
(Last) (First) (Middle)
6320 CANOGA AVENUE
(Street)
WOODLAND HILLS CA 91367
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ENDONOVO THERAPEUTICS, INC. [ ENDV ] 5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
X Officer (give title below) Other (specify below)
President
3. Date of Earliest Transaction (Month/Day/Year)
09/05/2017
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr.
4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/05/2017 P 11,000 A $0.0258 23,085,189 D
Common Stock 09/05/2017 P 2,000 A $0.0259 23,087,189 D
Common Stock 09/05/2017 P 3,000 A $0.0259 23,090,189 D
Common Stock 09/05/2017 P 5,000 A $0.0258 23,095,189 D
Common Stock 09/05/2017 P 5,000 A $0.0258 23,100,189 D
Common Stock 09/05/2017 P 10,000 A $0.0259 23,110,189 D
Common Stock 09/05/2017 P 10,000 A $0.0259 23,120,189 D
Common Stock 09/05/2017 P 5,000 A $0.0258 23,125,189 D
Common Stock 09/05/2017 P 5,000 A $0.0259 23,130,189 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Michael Mann 09/07/2017
Mann Michael Scott
(Last) (First) (Middle)
6320 CANOGA AVENUE
(Street)
WOODLAND HILLS CA 91367
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ENDONOVO THERAPEUTICS, INC. [ ENDV ] 5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
X Officer (give title below) Other (specify below)
President
3. Date of Earliest Transaction (Month/Day/Year)
09/05/2017
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr.
4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price
Common Stock 09/05/2017 P 11,000 A $0.0258 23,085,189 D
Common Stock 09/05/2017 P 2,000 A $0.0259 23,087,189 D
Common Stock 09/05/2017 P 3,000 A $0.0259 23,090,189 D
Common Stock 09/05/2017 P 5,000 A $0.0258 23,095,189 D
Common Stock 09/05/2017 P 5,000 A $0.0258 23,100,189 D
Common Stock 09/05/2017 P 10,000 A $0.0259 23,110,189 D
Common Stock 09/05/2017 P 10,000 A $0.0259 23,120,189 D
Common Stock 09/05/2017 P 5,000 A $0.0258 23,125,189 D
Common Stock 09/05/2017 P 5,000 A $0.0259 23,130,189 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr.
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Michael Mann 09/07/2017
(0)
(0)Endonovo Therapeutics, Inc. (ENDV) Stock Research Links
WORDS TO LIVE BY:
Never argue with stupid people, they will drag you down to their level and then beat you with experience.
Get .... PrivacyLok https://cyberidguard.com/
Try SafeVchat: https://cyberidguard.com/
My comments are only my opinion and are not to be used for investment advice.
Please conduct your own due diligence before choosing to buy or sell any stock.
Never argue with stupid people, they will drag you down to their level and then beat you with experience.
Get .... PrivacyLok https://cyberidguard.com/
Try SafeVchat: https://cyberidguard.com/
My comments are only my opinion and are not to be used for investment advice.
Please conduct your own due diligence before choosing to buy or sell any stock.
Scroll down for more posts ▼